Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Fv-IgG) (BSDG-032)

Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD15 IgG with similar domains from an anti-CD64 antibody via short peptide linkers, or vice versa. This BsAb can retarget neutrophils to tumor cells. It is designed for the research of Leukemia therapy.

Datasheet

Specifications

Targets

CD15 & CD64

Type

Appended IgGs

Species Reactivity

Human

Target 1

CD15

Host Animal 1

Mouse

Target 2

CD64

Host Animal 2

Mouse

Application

FuncS; Promising therapeutic agent

Related Disease

Leukemia

Targets

Target 1

CD15

Gene ID

2526

UniProt ID

P22083

Alternative Names

FUT4; fucosyltransferase 4; LeX; CD15; ELFT; FCT3A; FUTIV; SSEA-1; FUC-TIV; 3-FAL; 3-fucosyl-N-acetyllactosamine; stage-specific embryonic antigen-1; Lewis X; X-hapten

Target 2

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Our services and products are only for lab research, not for any diagnostic or therapeutic use.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY

Online Inquiry

USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Germany
Heidenkampsweg 58, 20097 Hamburg, Germany
Email:

UK
167-169 Great Portland Street, 5th Floor, London, W1W 5PE
Tel: 44-207-097-1828
Email: